Тревога и нарушения сна в общесоматической практике

Тревога и нарушения сна являются актуальной проблемой современного здравоохранения, лечение которых необходимо проводить на максимально возможных ранних этапах, поскольку это позволит предотвратить развитие широкого спектра осложнений данных состояний. При этом, учитывая двунаправленную связь между тревогой и нарушениями сна, все большую актуальность приобретают поиск и разработка безопасных и эффективных средств для их коррекции. В качестве основных методов терапии тревожных расстройств и нарушений сна рассматривается назначение комплекса мероприятий немедикаментозного и медикаментозного характера. В данной работе представлены диагностические инструменты, позволяющие врачу общесоматической практики как можно раньше выявить тревогу и нарушения сна (инсомнии) у пациента, и обсуждены терапевтические стратегии применения комбинации глицина с мелатонином у соответствующих больных.

1. Selye H. The story of the adaptation syndrome. Canada: Medical Publishers, 1952. 225 p.

2. Котова О.В., Акарачкова Е.С., Беляев А.А. Психовегетативный синдром: трудности диагностики и эффективного лечения // Медицинский совет. 2018;18(21):50–55. https://doi. org/10.21518/2079–701X 2018–21–50–55

3. Эбзеева Е.Ю., Полякова О.А. Тревожные расстройства и нарушения сна // Медицинский совет. 2022;16(11):108–113. https://doi.org/10.21518/2079–701X 2022–16–11–108–113

4. Somers JM, Goldner EM, Waraich P. et al. Prevalence and incidence studies of anxiety disorders: a systematic review of the literature. Can. J. Psychiatry. 2006;51(2):100–113. https://doi.org/10.1177/070674370605100206

5. Martín-Merino E, Ruigómez A, Wallander MA. et al. Prevalence, incidence, morbidity and treatment patterns in a cohort of patients diagnosed with anxiety in UK primary care. Fam. Pract. 2010;27(1):9–16. https://doi.org/10.1093/fampra/cmp071

6. Остроумова Т.М., Парфенов В.А., Остроумова О.Д. и др. Артериальная гипертензия и инсомния // Терапевтический архив. 2020;92(1):69–75. https://doi.org/10.26442/00403660.2 020.01.000319

7. Morphy H, Dunn KM, Lewis M. et al. Epidemiology of insomnia: a longitudinal study in a UK population. Sleep. 2007;30(3):274–280. https://doi.org/10.1093/sleep/30.3.274

8. Wilson S, Anderson K, Baldwin D. et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update. J. Psychopharmacol. 2019;33(8):923–947. https://doi.org/10.1177/0269881119855343

9. Staines AC, Broomfield N, Pass L. et al. Do non-pharmacological sleep interventions affect anxiety symptoms? A meta-analysis. J. Sleep. Res. 2022;31(1): e13451. https://doi. org/10.1111/jsr.13451

10. Cox R. C., Olatunji B. O. A systematic review of sleep disturbance in anxiety and related disorders. J. Anxiety. Disord. 2016;37:104–129. https://doi.org/10.1016/j.janxdis.2015.12.001

11. Stein M.B., Enns M.W., Kryger M.H. Sleep in nondepressed patients with panic disorder: II. Polysomnographic assessment of sleep architecture and sleep continuity. J. Affect. Disord. 1993;28(1):1–6. https://doi.org/10.1016/0165–0327(93)90071-q

12. Alfano C.A., Patriquin M.A., De Los Reyes A. Subjective – objective sleep comparisons and discrepancies among clinically-anxious and healthy children. J. Abnorm. Child. Psychol. 2015;43(7):1343–1353. https://doi.org/10.1007/s10802–015–0018–7

13. Soehner AM, Harvey AG. Prevalence and functional consequences of severe insomnia symptoms in mood and anxiety disorders: results from a nationally representative sample. Sleep. 2012;35(10):1367–1375. https://doi.org/10.5665/sleep.2116

14. Foley JE, Weinraub M. Sleep, Affect, and Social Competence from Preschool to Preadolescence: Distinct Pathways to Emotional and Social Adjustment for Boys and for Girls. Front Psychol. 2017;8:711. https://doi.org/10.3389/fpsyg.2017.00711

15. Lovato N, Gradisar M. A meta-analysis and model of the relationship between sleep and depression in adolescents: recommendations for future research and clinical practice. Sleep. Med. Rev. 2014;18(6):521–529. https://doi.org/10.1016/j.smrv.2014.03.006

16. McMakin DL, Alfano CA. Sleep and anxiety in late childhood and early adolescence. Curr. Opin. Psychiatry. 2015;28(6):483–489. https://doi.org/10.1097/YCO.0000000000000204

17. LeBlanc M, Mérette C, Savard J. et al. Incidence and risk factors of insomnia in a population-based sample. Sleep. 2009;32(8):1027–1037. https://doi.org/10.1093/sleep/32.8.1027

18. Taylor D.J., Mallory L.J., Lichstein K.L. et al. Comorbidity of chronic insomnia with medical problems. Sleep. 2007;30(2):213–218. https://doi.org/10.1093/sleep/30.2.213

19. Neckelmann D, Mykletun A, Dahl AA. Chronic insomnia as a risk factor for developing anxiety and depression. Sleep. 2007;30(7):873–880. https://doi.org/10.1093/ sleep/30.7.873

20. Драпкина О.М., Концевая А.В., Калинина А.М. и др. Профилактика хронических неинфекционных заболеваний в Российской Федерации. Национальное руководство 2022. Кардиоваскулярная терапия и профилактика. 2022;21(4):5–232. https://doi.org/10.15829/1728– 8800–2022–3235

21. Есин Р.Г., Есин О.Р., Хакимова А.Р. Стресс-индуцированные расстройства // Журнал неврологии и психиатрии им. С.С. Корсакова. 2020;120(5):131–137. https://doi.org/10.17116/ jnevro2020120051131

22. Тревожно-фобические расстройства. Клинические рекомендации, утвержденные Минздравом России (2021). Режим доступа: https://cr.minzdrav.gov.ru/recomend/455_2

23. Сомнология и медицина сна: Национальное руководство памяти А.М. Вейна и Я.И. Левина / под ред. М.Г. Полуэктова. М.: Мед-форум, 2016. 660 с.

24. Ковальзон В.М. Основы сомнологии: физиология и нейрохимия цикла «бодрствование–сон». М.: БИНОМ. Лаборатория знаний, 2012. 239 с.

25. Остроумова О.Д., Кочетков А.И., Эбзеева Е.Ю. и др. Инсомния и полиморбидность: учеб. пособие. М.: ФГБОУ ДПО РМАНПО Минздрава России, 2021. 76 с.

26. Sateia MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest. 2014;146(5):1387–1394. https://doi.org/10.1378/chest.14–0970

27. Шишкова В.Н., Нарциссов Я. Р., Титова В.Ю. и др. Молекулярные механизмы, определяющие применение комбинации глицина и цинка в коррекции основных проявлений стресса и тревоги // Фармация и фармакология. 2022;10(5):404–415. https://doi. org/10.19163/2307–9266–2022–10–5–404–415

28. Karna B, Sankari A, Tatikonda G. Sleep Disorder. In: StatPearls. Treasure Island (FL): StatPearls Publishing; January 26, 2023.

29. Godos J, Currenti W, Angelino D. et al. Diet and Mental Health: Review of the Recent Updates on Molecular Mechanisms. Antioxidants (Basel). 2020;9(4):346. https://doi. org/10.3390/antiox9040346

30. File SE, Fluck E, Fernandes C. Beneficial effects of glycine (bioglycin) on memory and attention in young and middle-aged adults. J. Clin. Psychopharmacol. 1999;19(6):506–512. https://doi.org/10.1097/00004714–199912000–00004

31. Inagawa K, Hiraoka T, Kohda T. et al. Subjective effects of glycine ingestion before bedtime on sleep quality. Sleep and Biological Rhythms. 2006;4(1):75–77. https://doi. org/10.1111/j.1479–8425.2006.00193.x

32. Yamadera W, Inagawa K, Chiba S. et al. Glycine ingestion improves subjective sleep quality in human volunteers, correlating with polysomnographic changes. Sleep and Biological Rhythms. 2007;5(2):126–131. https://doi.org/10.1111/j.1479–8425.2007.00262.x

33. Inagawa K, Kawai N, Ono K. et al. Assessment of acute adverse events of glycine ingestion at a high dose in human volunteers. J. Urban. Living. Health Assoc. 2006;50:27–32.

34. Razak MA, Begum PS, Viswanath B. et al. Multifarious Beneficial Effect of Nonessential Amino Acid, Glycine: A Review. Oxid. Med. Cell. Longev. 2017;2017:1716701. https://doi. org/10.1155/2017/1716701

35. Pérez-Torres I, Zuniga-Munoz AM, Guarner-Lans V. Beneficial Effects of the Amino Acid Glycine. Mini Rev. Med. Chem. 2017;17(1):15–32. https://doi.org/10.2174/1389557516666160609081602

36. Bartlett DJ, Biggs SN, Armstrong SM. Circadian rhythm disorders among adolescents: assessment and treatment options. Med. J. Aust. 2013;199(8): S16–S20. https://doi. org/10.5694/mja13.10912

37. Takaesu Y, Futenma K, Kobayashi M. et al. A preliminary study on the relationships between diurnal melatonin secretion profile and sleep variables in patients emergently admitted to the coronary care unit. Chronobiol. Int. 2015;32(6):875–879. https://doi.org /10.3109/07420528.2015.1048869

38. Xie Z, Chen F, Li WA. et al. A review of sleep disorders and melatonin. Neurol. Res. 2017;39(6):559–565. https://doi.org/10.1080/01616412.2017.1315864

39. Geoffroy PA, Etain B, Franchi JA. et al. Melatonin and Melatonin Agonists as Adjunctive Treatments in Bipolar Disorders. Curr. Pharm. Des. 2015;21(23):3352–3358. https://doi.or g/10.2174/1381612821666150619093448

40. Galley HF, Lowes DA, Allen L. et al. Melatonin as a potential therapy for sepsis: a phase I dose escalation study and an ex vivo whole blood model under conditions of sepsis. J. Pineal. Res. 2014;56(4):427–438. https://doi.org/10.1111/jpi.12134

41. Chang YS, Lin MH, Lee JH. et al. Melatonin Supplementation for Children With Atopic Dermatitis and Sleep Disturbance: A Randomized Clinical Trial. JAMA Pediatr. 2016;170(1):35–42. https://doi.org/10.1001/jamapediatrics.2015.3092

42. Lähteenmäki R, Puustinen J, Vahlberg T. et al. Melatonin for sedative withdrawal in older patients with primary insomnia: a randomized double-blind placebo-controlled trial. Br.J. Clin. Pharmacol. 2014;77(6):975–985. https://doi.org/10.1111/bcp.12294

43. Amstrup AK, Sikjaer T, Mosekilde L. et al. The effect of melatonin treatment on postural stability, muscle strength, and quality of life and sleep in postmenopausal women: a randomized controlled trial. Nutr. J. 2015;14:102. https://doi.org/10.1186/s12937–015–0093–1

44. Scheer FA, Morris CJ, Garcia JI. et al. Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial. Sleep. 2012;35(10):1395–1402. https://doi.org/10.5665/sleep.2122

45. Gumenyuk V, Belcher R, Drake CL. et al. Differential sleep, sleepiness, and neurophysiology in the insomnia phenotypes of shift work disorder. Sleep. 2015;38(1):119–126. https://doi.org/10.5665/sleep.4336

46. Kaminski RS, Martinez D, Fagundes M. et al. Melatonin prevents hyperglycemia in a model of sleep apnea. Arch. Endocrinol. Metab. 2015;59(1):66–70. https://doi. org/10.1590/2359–3997000000012

47. Xie S, Deng Y, Pan YY– et al. Melatonin protects against chronic intermittent hypoxia-induced cardiac hypertrophy by modulating autophagy through the 5’ adenosine monophosphate-activated protein kinase pathway. Biochem. Biophys. Res. Commun. 2015;464(4):975–981. https://doi.org/10.1016/j.bbrc.2015.06.149

48. Yeung HM, Hung MW, Lau CF. et al. Cardioprotective effects of melatonin against myocardial injuries induced by chronic intermittent hypoxia in rats. J. Pineal Res. 2015;58(1):12–25. https://doi.org/10.1111/jpi.12190

49. Abadir PM, Periasamy A, Carey RM. et al. Angiotensin II type 2 receptor-bradykinin B2 receptor functional heterodimerization. Hypertension. 2006;48(2):316–322. https://doi. org/10.1161/01.HYP.0000228997.88162.a8

50. Sabatini RA, Guimarães PB, Fernandes L. et al. ACE activity is modulated by kinin B2 receptor. Hypertension. 2008;51(3):689–695. https://doi.org/10.1161/HYPERTENSIONAHA.107.091181